Asensus Surgical is digitising the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons
The Senhance Surgical System has open-platform architecture. (Credit: Asensus Surgical, Inc.)
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the installation of a Senhance® Surgical System in the General Surgery Department of Evangelical Hospital Goettingen-Weende of Göttingen, Germany. This agreement to lease and utilize a Senhance® Surgical System was one of two announced by the Company on August 8, 2022.
“Goettingen-Weende has a significant laparoscopic program within their general surgery department. We are excited to bring the benefits of Senhance’s digital laparoscopy and Performance-Guided Surgery to these experienced surgeons,” said Anthony Fernando, Asensus Surgical President and CEO. “We look forward to collaborating with the Goettingen-Weende team to work towards increasing utilization of their Senhance system to help provide enhanced care to their patients.”
Asensus Surgical’s technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform. It leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU™). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field. It allows a surgeon to change the visualized field of view using the movement of their instruments. The newest ISU features expand upon these capabilities and introduce more advanced features including: 3D measurement, digital tagging, image enhancement, and enhanced camera control based on real-time data from anatomical structures while performing surgery.
“The Senhance platform is a compelling new option for our surgeons and it is an important addition to our laparoscopic department, which provides a large number of minimally invasive surgeries,” said Professor Claus Langer, Head of the General, Visceral, and Thoracic Surgery Department. “This cutting-edge robotic technology enhances what a surgeon can see and do during surgery which greatly benefits our patients.”
Source: Company Press Release